Prestige Wealth Management Group LLC Horizon Therapeutics Public LTD CO Transaction History

Prestige Wealth Management Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2024	BUY	$107.32 - $113.5 $17,063 - $18,046	159 New	159 $17,000
Q1 2023 May 16, 2023	SELL	$107.32 - $113.5 $4,614 - $4,880	-43 Reduced 21.29%	159 $17,000
Q4 2022 Feb 07, 2023	SELL	$62.39 - $113.8 $6,675 - $12,176	-107 Reduced 34.63%	202 $22,000
Q3 2022 Nov 01, 2022	BUY	$58.92 - $84.67 $4,124 - $5,926	70 Added 29.29%	309 $19,000
Q2 2022 Aug 10, 2022	BUY	$79.4 - $116.36 $2,858 - $4,188	36 Added 17.73%	239 $19,000

Q1 2022 May 05, 2022	SELL	$86.42 - $109.81 $1,209 - $1,537	-14 Reduced 6.45%	203 $22,000
Q4 2021 Feb 15, 2022	SELL	$98.56 - $119.91 $6,209 - $7,554	-63 Reduced 22.5%	217 $24,000
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $9,099 - $10,926	-99 Reduced 26.12%	280 $30,000
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $6,812 - $7,577	79 Added 26.33%	379 $35,000
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $2,487 - $3,856	100 Added 50.0%	300 $9,000
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $4,600 - $5,594	200 New	200 $5,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prestige Wealth Management Group LLC with notifications on news.